Genomic & Biopharma NewsStudy identifies key mediator in learning process
The ability of the brain to respond and adapt to changes is scientifically called brain plasticity. This ability is the basis of all learning processes.
|News Medical Life Sciences, 2017-04-07 16:08:03|
Keeping the Blood Supply Zika-Free
Blood donation centers across the U.S. are required to screen samples for signs of the mosquito-borne virus. Some have questioned whether it's always necessary.
|The Scientist, 2017-04-07 16:00:00|
Restasis' first foray into Facebook drives big results for Allergan
Restasis' first foray into Facebook drives big results for Allergan beth.bulik Fri, 04/07/2017 - 11:42
|Fierce Pharma, 2017-04-07 15:42:11|
UC Riverside professor receives grant to explore therapeutic target for treating IBD patients
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the intestine that includes Crohn's disease and ulcerative colitis. A protective protein that plays a key role in this disease is "T-cell protein tyrosine phosphatase" or TCPTP.
|News Medical Life Sciences, 2017-04-07 15:24:39|
Gilead notches pediatric use for Sovaldi, Harvoni as sales fade among adults
Gilead notches pediatric use for Sovaldi, Harvoni as sales fade among adults esagonowsky Fri, 04/07/2017 - 11:13
|Fierce Pharma, 2017-04-07 15:13:19|
FDA allows 23andMe to sell DTC genetic tests for 10 conditions
FDA allows 23andMe to sell DTC genetic tests for 10 conditions aalidrus Fri, 04/07/2017 - 11:04
|Fierce Biotech, 2017-04-07 15:04:02|
Study compares insulin pump therapy and injections in type 1 diabetes patients during Ramadan fasting
A new study examining the risk of fasting during Ramadan for people with type 1 diabetes compared blood glucose control and the rates of hypoglycemia and hyperglycemia between users of insulin pump therapy versus multiple daily insulin injections.
|News Medical Life Sciences, 2017-04-07 14:54:50|
Patients with inducible urticaria can benefit from treatment with asthma drug
Patients who develop itchy wheals in response to cold or friction benefit from treatment with omalizumab, a drug normally used to treat asthma.
|News Medical Life Sciences, 2017-04-07 14:48:42|
Amgen CEO Bradway sees pay package grow $750K to $16.85M in solid year
Amgen CEO Bradway sees pay package grow $750K to $16.85M in solid year epalmer Fri, 04/07/2017 - 10:48
|Fierce Pharma, 2017-04-07 14:48:12|